These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32092228)

  • 1. Improved inference for fixed-effects meta-analysis of 2 × 2 tables.
    Qijun Li K; Rice K
    Res Synth Methods; 2020 May; 11(3):387-396. PubMed ID: 32092228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment.
    Pagliaro L; D'Amico G; Sörensen TI; Lebrec D; Burroughs AK; Morabito A; Tiné F; Politi F; Traina M
    Ann Intern Med; 1992 Jul; 117(1):59-70. PubMed ID: 1350716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The exact distribution of Cochran's heterogeneity statistic in one-way random effects meta-analysis.
    Biggerstaff BJ; Jackson D
    Stat Med; 2008 Dec; 27(29):6093-110. PubMed ID: 18781561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for estimating between-study variance and overall effect in meta-analysis of odds ratios.
    Bakbergenuly I; Hoaglin DC; Kulinskaya E
    Res Synth Methods; 2020 May; 11(3):426-442. PubMed ID: 32112619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Odds Ratios: Current Good Practices.
    Chang BH; Hoaglin DC
    Med Care; 2017 Apr; 55(4):328-335. PubMed ID: 28169977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining heterogeneity in meta-analysis: a comparison of methods.
    Thompson SG; Sharp SJ
    Stat Med; 1999 Oct; 18(20):2693-708. PubMed ID: 10521860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantel-Haenszel-type inference for cumulative odds ratios with a stratified ordinal response.
    Liu IM; Agresti A
    Biometrics; 1996 Dec; 52(4):1223-34. PubMed ID: 8962452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A generalized-weights solution to sample overlap in meta-analysis.
    Bom PRD; Rachinger H
    Res Synth Methods; 2020 Nov; 11(6):812-832. PubMed ID: 32790019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating underlying risk as a source of heterogeneity in meta-analysis.
    Thompson SG; Smith TC; Sharp SJ
    Stat Med; 1997 Dec; 16(23):2741-58. PubMed ID: 9421873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permutation inference methods for multivariate meta-analysis.
    Noma H; Nagashima K; Furukawa TA
    Biometrics; 2020 Mar; 76(1):337-347. PubMed ID: 31399994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses.
    Langan D; Higgins JPT; Jackson D; Bowden J; Veroniki AA; Kontopantelis E; Viechtbauer W; Simmonds M
    Res Synth Methods; 2019 Mar; 10(1):83-98. PubMed ID: 30067315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Odds ratio for 2 × 2 tables: Mantel-Haenszel estimator, profile likelihood, and presence of surrogate responses.
    Banerjee B; Biswas A
    J Biopharm Stat; 2014; 24(3):649-59. PubMed ID: 24697719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved method for bivariate meta-analysis when within-study correlations are unknown.
    Hong C; D Riley R; Chen Y
    Res Synth Methods; 2018 Mar; 9(1):73-88. PubMed ID: 29055096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods to estimate the between-study variance and its uncertainty in meta-analysis.
    Veroniki AA; Jackson D; Viechtbauer W; Bender R; Bowden J; Knapp G; Kuss O; Higgins JP; Langan D; Salanti G
    Res Synth Methods; 2016 Mar; 7(1):55-79. PubMed ID: 26332144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of methods for meta-analysis of a small number of studies with binary outcomes.
    Mathes T; Kuss O
    Res Synth Methods; 2018 Sep; 9(3):366-381. PubMed ID: 29573180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confidence intervals for the between-study variance in random effects meta-analysis using generalised Cochran heterogeneity statistics.
    Jackson D
    Res Synth Methods; 2013 Sep; 4(3):220-9. PubMed ID: 26053842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection sclerotherapy for esophageal varices.
    Aberra E; Huttunen R
    Ann Chir Gynaecol; 1992; 81(4):357-61. PubMed ID: 1485788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerotherapy versus vasoactive drugs: are all meta-analyses the same?
    Triantos C; Samonakis D; Patch D; Burroughs A; Goulis J
    Gastroenterology; 2004 Jul; 127(1):358-9; author reply 359-60. PubMed ID: 15236217
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial.
    Gonçalves ME; Cardoso SR; Maksoud JG
    J Pediatr Surg; 2000 Mar; 35(3):401-5. PubMed ID: 10726678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacologic treatment or endoscopic sclerotherapy as primary intervention for bleeding varices in cirrhotic patients].
    Grønbaek H; Dahlerup JF; Vilstrup H
    Ugeskr Laeger; 2003 Mar; 165(11):1127-30. PubMed ID: 12677989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.